AVAlain Viel

Alain Viel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alain Viel has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Suzanne Gaudet

    Department of Cancer Biology and Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA

    2 shared publications
  • Aaron Deardon

    Harvard College, Harvard University, Cambridge, MA, 02138, USA

    1 shared publication
  • Anugraha M Raman

    Harvard College, Harvard University, Cambridge, MA, 02138, USA

    1 shared publication
  • Christina M Agapakis

    Department of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA

    1 shared publication
  • Dawna Ellston

    From the ‡Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, the §Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and the ¶Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129

    1 shared publication
  • Devin R Burrill

    Department of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA

    1 shared publication

Latest Publications

  • Open Access

    A BioBrick compatible strategy for genetic modification of plants

    by Patrick M Boyle, Devin R Burrill, Mara C Inniss, Christina M Agapakis, Aaron Deardon, Jonathan G DeWerd, Michael A Gedeon, Jacqueline Y Quinn, Morgan L Paull, Anugraha M Raman, et al.

    Background: Plant biotechnology can be leveraged to produce food, fuel, medicine, and materials. Standardized methods advocated by the synthetic biology community can accelerate the plant design cycle, ultimately making plant engineering more widely accessible to bioengineers who can contribute diverse creative input to the design process. Results: This paper presents work done largely by undergraduate students participating in the 2010 International Genetically Engineered Machines (iGEM) competition. Described here is a framework for engineering the model plant Arabidopsis thaliana with standardized, BioBrick compatible vectors and parts available through the Registry of Standard Biological Parts (http://www.partsregistry.org). This system was used to engineer a proof-of-concept plant that exogenously expresses the taste-inverting protein miraculin. Conclusions: Our work is intended to encourage future iGEM teams and other synthetic biologists to use plants as a genetic chassis. Our workflow simplifies the use of standardized parts in plant systems, allowing the construction and expression of heterologous genes in plants within the timeframe allotted for typical iGEM projects.


  • Open Access

    The MEK2-binding tumor suppressor hDlg is recruited by E-cadherin to the midbody ring

    by Suzanne Gaudet, Marie-Josée Langlois, Robert A Lue, Nathalie Rivard, Alain Viel

    The human homologue of the Drosophila Discs-large tumor suppressor protein, hDlg, is a multi-domain cytoplasmic protein that localizes to the membrane at intercellular junction sites. At both synaptic junctions and epithelia cell-cell junctions, hDlg is known to recruit several signaling proteins into macromolecular complexes. hDlg is also found at the midbody, a small microtubule-rich structure bridging the two daughter cells during cytokinesis, but its function at this site is not clear.


  • Open Access

    The Distribution and Function of Alternatively Spliced Insertions in hDlg

    by Margaret McLaughlin, Robert Hale, Dawna Ellston, Suzanne Gaudet, Robert A. Lue, Alain Viel